Navigation Links
Mylan Launches Commercial Operations in India, Starting with a Broad, Innovative Portfolio of ARV Products to Treat HIV/AIDS
Date:8/5/2012

ts ARV franchise, and the company's ARV products are used by nearly one-third of all people receiving treatment today for HIV/AIDS in the developing world.

Mylan President Rajiv Malik said, "Mylan has helped to significantly drive down the cost of ARV therapies, while ensuring that quality remains paramount. Globally, we now offer a portfolio of 43 innovative, high quality ARV drugs, and the launch of 18 of these products in India represents an exciting first step in this important market. Since Mylan's founding more than 50 years ago, we have been committed to filling unmet needs with our quality products, and we intend to maintain these same high standards with the products we sell in India."

Mylan's Nashik, India facility, which produces the company's finished-dosage-form ARVs for markets around the world including India, has been subject to Good Manufacturing Practices (GMP) inspections by several leading regulatory authorities, including the U.S. Food and Drug Administration (FDA) and the World Health Organization (WHO).

Mylan also has introduced a number of ARV innovations, for instance producing single blister "combo" packs, which provide a reduced pill burden and once-a-day dosage. Mylan also developed three FDA/WHO-approved heat-stable ARV products, which can be distributed and used in warm climates where refrigeration infrastructure is not widely available. In addition, Mylan has been a global leader in producing ARV formulations for pediatric use. 

Mylan's India Launch
A Mylan sales force—one of the largest field forces exclusively specializing in HIV/AIDS in India—will leverage the company's global expertise to market Mylan's high-quality, innovative ARV portfolio to HIV/AIDS specialists across the country. The Mylan portfolio will initially include a comprehensive range of 18 products, including heat stable, combination, and pediatric formulations.

In addition to providing a broad range of ARV
'/>"/>

SOURCE Mylan Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Mylan Launches Generic Version of Zyprexa® Tablets
2. Mylan and Pfizer Announce Epinephrine Auto-injector Settlement Agreement with Teva
3. Mylan Reports Q1 2012 Adjusted Diluted EPS of $0.52, an 18% Increase Over Prior Year Quarter
4. Mylan Launches Generic Lipitor® in Five European Countries
5. Mylan Launches Generic Version of Plavix® Tablets
6. Mylan Sponsors Drug Store News and Pharmacist Society to Provide a New Business Networking Platform for Pharmacy Schools and Students
7. Mylan Launches Generic Version of Viramune® Tablets
8. Mylan Launches Generic Version of Bonviva® Film Coated Tablets in the UK and Italy
9. Mylan Announces Settlement Agreement in Patent Infringement Litigation Relating to Sunovions Brovana® Product
10. Mylan Announces Settlement Agreement in Litigation Relating to its Generic Xopenex®
11. Mylan Launches Generic Version of Lipitor®
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2014)... YORK , Nov. 26, 2014 ... growing at a rate of 4%, with world ... to Kalorama Information. MRI and other types of ... diagnosis and treatment of numerous medical conditions in ... technologies and techniques. Kalorama,s report, Medical Imaging ...
(Date:11/26/2014)... 25, 2014  At the American Dental Association,s Annual ... October, KaVo Kerr Group was honored to be part ... the opportunity to see and test the Best of ... deliver lectures on the latest developments in dental technology. ... new DEXIS CariVu Caries Detection Device and Kerr Demi ...
(Date:11/26/2014)... 25, 2014  Medtronic,s roughly $43 billion ... widely discussed in the media for its US ... stronger leading player in one of the fastest ... healthcare market research firm said  the two companies ... diverse set of solutions spanning inpatient to home ...
Breaking Medicine Technology:Kalorama: Steady Growth in the Medical MRI Market 2Kalorama: Steady Growth in the Medical MRI Market 3KaVo Kerr Group Showcased in Pride Institute Technology Expo at ADA Annual Meeting 2KaVo Kerr Group Showcased in Pride Institute Technology Expo at ADA Annual Meeting 3Medtronic - Covidien: Beyond Taxes, Deal Will Create Patient Monitoring Power, according to Kalorama Information 2Medtronic - Covidien: Beyond Taxes, Deal Will Create Patient Monitoring Power, according to Kalorama Information 3
... ViroPharma Incorporated (Nasdaq: VPHM ) today provided ... [Human]) manufacturing expansion activities.   , ... ViroPharma is increasing its Cinryze ... parallel chromatography process, was implemented earlier this year and allows ...
... , June 21, 2010 Zydus Cadila, a global,healthcare provider ... clinical trial permission from the DCGI for ZYOG1 - a novel,GLP-1 agonist. ... ZYOG1 is a novel, oral, anti-diabetic molecule. , ... The new class of anti-diabetic ...
Cached Medicine Technology:ViroPharma Files Prior Approval Supplement (PAS) for Cinryze™ (C1 Esterase Inhibitor [Human]) Industrial Scale Manufacturing 2ViroPharma Files Prior Approval Supplement (PAS) for Cinryze™ (C1 Esterase Inhibitor [Human]) Industrial Scale Manufacturing 3ViroPharma Files Prior Approval Supplement (PAS) for Cinryze™ (C1 Esterase Inhibitor [Human]) Industrial Scale Manufacturing 4ViroPharma Files Prior Approval Supplement (PAS) for Cinryze™ (C1 Esterase Inhibitor [Human]) Industrial Scale Manufacturing 5ViroPharma Files Prior Approval Supplement (PAS) for Cinryze™ (C1 Esterase Inhibitor [Human]) Industrial Scale Manufacturing 6Zydus' Novel Orally Administered GLP-1 Agonist - 'ZYOG1' to treat Diabetes and Obesity Enters Phase I Clinical Trial 2Zydus' Novel Orally Administered GLP-1 Agonist - 'ZYOG1' to treat Diabetes and Obesity Enters Phase I Clinical Trial 3
(Date:11/28/2014)... UWDress.com sells cheap tall cocktail dresses worldwide ... Today, there is a new collection of tall cocktail ... offered at very low prices. It is really worthy ... launched by UWDress.com , UWDress.com is one of the ... company has the power to ensure customer satisfaction. Now, ...
(Date:11/28/2014)... York, NY (PRWEB) November 28, 2014 ... physical therapy techniques such as Dynamic Neuromuscular Stabilization, ... and gait/motion analysis. After moving to upgraded facilities ... and running clinic. Now, owner Dr. Lev Kalika ... performance and injury prevention lab in the country. ...
(Date:11/28/2014)... (PRWEB) November 29, 2014 The holiday season ... has recently announced its new collection of fashionable party dresses. ... 80% off, on all these brand new outfits; the special ... is a renowned online supplier and it has received ... company’s new items are specially designed to flatter various body ...
(Date:11/28/2014)... November 28, 2014 Brosix is always ... of providing users with a more efficient, effective, and ... of upgrades, including: , 1. The ability to setup ... allow Brosix to better service customers around the globe. ... of servers for large customers that require millions of ...
(Date:11/28/2014)... Novatus, a leading provider of contract ... provides customers with greater reporting capabilities, more searchable ... we continue to evolve and grow the Novatus ... improved performance in response to requests from our ... the enhancements that we have made to Advanced ...
Breaking Medicine News(10 mins):Health News:Graceful Tall Cocktail Dresses With New Features Just Added To UWDress.com 2Health News:New York Dynamic Neuromuscular Rehabilitation Opens Nation's Most Advanced Movement Performance and Injury Prevention Lab 2Health News:New York Dynamic Neuromuscular Rehabilitation Opens Nation's Most Advanced Movement Performance and Injury Prevention Lab 3Health News:Trendy Party Dresses For The Coming Holiday Season From Balfleet.com 2Health News:Brosix Infrastructure Architecture Changes to Benefit Users 2Health News:Novatus Releases v5.1 with New Advanced Reporting Capabilities 2
... to hold the, line on health care cost increases. ... RAPIDS, Mich., Feb. 15 Experts predict,health care costs ... impact of,these increases will have a major effect on ... while others are competing globally,for high tech talent. What ...
... part of new parent company for ... Batesville Casket Company, Stand alone medical technology ... doing business under well-known Hill-Rom brand, ... announced today that it has begun mailing a,notice regarding a special shareholder ...
... masses, study finds , , FRIDAY, Feb. 15 (HealthDay News) ... of two types of hard-to-treat pediatric tumors without harming ... viral therapy, dubbed rQT3, slowed neuroblastoma and peripheral nerve ... the Feb. 15 issue of Cancer Research . ...
... Calif., Feb. 15 Anti-Aging Formulas LLC,( http://www.renuva.net ... and,Mineral Spray, an oral spray with a proprietary ... multivitamin pills., Videos: ... "Unlike tablets, capsules and pills, our Daily ...
... Wis., Feb. 15 Nerites Corporation, a company,that ... medical,devices, today announced it has completed a $5.7 ... of Madison, Wisconsin, with participation by,Black Mountain Ventures ... had raised $3 million from private investors., ...
... specific antigen (PSA) test taken before the age of 50 ... up to 25 years in advance of a diagnosis, according ... Cancer Center in New York and Lund University in Sweden. ... Medicine, should help physicians be able to identify men who ...
Cached Medicine News:Health News:McGraw Wentworth Launches Survey to Benchmark Employee Benefit Trends in Michigan 2Health News:Hillenbrand Announces Mailing of Proxy Regarding Changing of Company Name in Conjunction with Planned Separation 2Health News:Hillenbrand Announces Mailing of Proxy Regarding Changing of Company Name in Conjunction with Planned Separation 3Health News:Hillenbrand Announces Mailing of Proxy Regarding Changing of Company Name in Conjunction with Planned Separation 4Health News:Hillenbrand Announces Mailing of Proxy Regarding Changing of Company Name in Conjunction with Planned Separation 5Health News:Viral Therapy Slows Pediatric Tumors in Mice 2Health News:New Renuva Daily Balance Spray Is Designed to Be the Easiest and Best Way to Take Daily Vitamins and Minerals 2Health News:Nerites Corporation Announces Closing of Series A Funding Round 2Health News:PSA testing can predict advanced prostate cancer 2
A complete workstation for haemostasis , A compact and convenient analyser , A comprehensive system , An exellent reliability: the STAGO patented detection mode...
... Ophthalmic Products are constructed of ... lint-free MEROCEL polyvinyl acetal sponge. ... be beneficial to both surgeon ... and yet firm enough to ...
Tenderlett finger incision devices are designed to fit the contour of the finger. Tenderlett is available in three different incision depths from toddler to adult and color-code for easy identificat...
... Haemolance Plus Safety Lancets help protect ... needle stick injuries and cross-contamination. Designed ... for needlestick safety, the needle is ... The Haemolance Plus features automatic lockout ...
Medicine Products: